These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7494169)

  • 21. The course of epiphora after failure of silicone intubation for congenital nasolacrimal duct obstruction.
    Kassif Y; Rehany U; David M; Popko A; Rumelt S
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):758-62. PubMed ID: 15756575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital euryblepharon and nasolacrimal anomalies in a patient with Down syndrome.
    Markowitz GD; Handler LF; Katowitz JA
    J Pediatr Ophthalmol Strabismus; 1994; 31(5):330-1. PubMed ID: 7837024
    [No Abstract]   [Full Text] [Related]  

  • 24. Endoscopic intranasal surgery for congenital nasolacrimal duct obstruction--a new approach.
    Korkmaz H; Korkmaz M; Karakahya RH; Serhatlı M
    Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):918-21. PubMed ID: 23541294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Congenital Nasolacrimal Duct Obstruction With Anatomic Anomalies.
    Arnold RW; Olitsky SE; Suh DW; Wasserman BN; Wagner RS
    J Pediatr Ophthalmol Strabismus; 2017 Jan; 54(1):6-9. PubMed ID: 28128841
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.
    Frick KD; Hariharan L; Repka MX; Chandler D; Melia BM; Beck RW;
    Arch Ophthalmol; 2011 May; 129(5):603-9. PubMed ID: 21555614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital nasolacrimal duct obstruction: irrigation or probing?
    Kim YS; Moon SC; Yoo KW
    Korean J Ophthalmol; 2000 Dec; 14(2):90-6. PubMed ID: 11213741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trauma to the lacrimal system in children.
    Billson FA; Taylor HR; Hoyt CS
    Am J Ophthalmol; 1978 Dec; 86(6):828-33. PubMed ID: 736082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary treatment of nasolacrimal duct obstruction.
    Rumelt S
    J AAPOS; 2009 Aug; 13(4):426; author reply 426-7. PubMed ID: 19683201
    [No Abstract]   [Full Text] [Related]  

  • 32. Endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction.
    Agarwal S
    J Laryngol Otol; 2009 Nov; 123(11):1226-8. PubMed ID: 19674493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal endoscopic silicone intubation for congenital obstruction of the nasolacrimal duct in children.
    Orhan M; Onerci M
    Int J Pediatr Otorhinolaryngol; 1997 Sep; 41(3):273-8. PubMed ID: 9350486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of congenital nasolacrimal system obstruction.
    Robb RM
    J Pediatr Ophthalmol Strabismus; 1985; 22(1):36-7. PubMed ID: 3981382
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of congenital nasolacrimal duct obstruction.
    Takahashi Y; Kakizaki H; Chan WO; Selva D
    Acta Ophthalmol; 2010 Aug; 88(5):506-13. PubMed ID: 19681790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follow-up after probing for congenital nasolacrimal duct obstruction.
    Burns SJ; Kipioti A
    J Pediatr Ophthalmol Strabismus; 2001; 38(3):163-5. PubMed ID: 11386649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eighteen-year follow-up study of a Scottish birth cohort with epiphora.
    Wallace J; MacEwen CJ
    Acta Ophthalmol; 2012 Dec; 90(8):e657-8. PubMed ID: 22489552
    [No Abstract]   [Full Text] [Related]  

  • 38. Superior lacrimal canalicular atresia and nasolacrimal duct obstruction in the CHARGE association.
    Bowling BS; Chandna A
    J Pediatr Ophthalmol Strabismus; 1994; 31(5):336-7. PubMed ID: 7837027
    [No Abstract]   [Full Text] [Related]  

  • 39. Success rates of nasolacrimal duct probing at time intervals after 1 year of age.
    Robb RM
    Ophthalmology; 1998 Jul; 105(7):1307-9; discussion 1309-10. PubMed ID: 9663238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital nasolacrimal duct obstruction continues trend for spontaneous resolution beyond first year of life.
    Nakayama T; Watanabe A; Rajak S; Yamanaka Y; Sotozono C
    Br J Ophthalmol; 2020 Aug; 104(8):1161-1163. PubMed ID: 31676597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.